Re-Configuration of Sphingolipid Metabolism by Oncogenic Transformation
Open Access
- 14 March 2014
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 4 (1) , 315-353
Abstract
The sphingolipids are one of the major lipid families in eukaryotes, incorporating a diverse array of structural variants that exert a powerful influence over cell fate and physiology. Increased expression of sphingosine kinase 1 (SPHK1), which catalyses the synthesis of the pro-survival, pro-angiogenic metabolite sphingosine 1-phosphate (S1P), is well established as a hallmark of multiple cancers. Metabolic alterations that reduce levels of the pro-apoptotic lipid ceramide, particularly its glucosylation by glucosylceramide synthase (GCS), have frequently been associated with cancer drug resistance. However, the simple notion that the balance between ceramide and S1P, often referred to as the sphingolipid rheostat, dictates cell survival contrasts with recent studies showing that highly potent and selective SPHK1 inhibitors do not affect cancer cell proliferation or survival, and studies demonstrating higher ceramide levels in some metastatic cancers. Recent reports have implicated other sphingolipid metabolic enzymes such as acid sphingomyelinase (ASM) more strongly in cancer pathogenesis, and highlight lysosomal sphingolipid metabolism as a possible weak point for therapeutic targeting in cancer. This review describes the evidence implicating different sphingolipid metabolic enzymes and their products in cancer pathogenesis, and suggests how newer systems-level approaches may improve our overall understanding of how oncogenic transformation reconfigures sphingolipid metabolism.Keywords
This publication has 280 references indexed in Scilit:
- Sphingosine 1-Phosphate and Cancer: Lessons from Thyroid Cancer CellsBiomolecules, 2013
- Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1‐phosphate signalling to regulate tumour metastasisEMBO Molecular Medicine, 2012
- Ceramide kinase regulates TNFα-stimulated NADPH oxidase activity and eicosanoid biosynthesis in neuroblastoma cellsCellular Signalling, 2012
- Sphingosine-1-phosphate signaling and its role in diseaseTrends in Cell Biology, 2012
- Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of SphingolipidomicsChemical Reviews, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The role of sphingosine kinase-1 in EGFRvIII-regulated growth and survival of glioblastoma cellsJournal of Neuro-Oncology, 2010
- Fatty acid 2-Hydroxylation in mammalian sphingolipid biologyBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Gangliosides in cell recognition and membrane protein regulationCurrent Opinion in Structural Biology, 2009
- Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): Attenuation of C18-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasisCancer Letters, 2007